The deal will give Lilly access to Adverum's gene therapy candidate, Ixo-vec, and underscores the U.S. drugmaker's focus on such treatmentsThe deal will give Lilly access to Adverum's gene therapy candidate, Ixo-vec, and underscores the U.S. drugmaker's focus on such treatments Latest News [ SOBAN NEWS: International and National ]
